Investors Seek GLP-1 Alternatives After Nausea Hurdles
A new wave of weight-loss therapies aims to beat current GLP-1 drugs by reducing side effects and daily dosing. Inves...
Which index fund performed best this year? Review top performers, volatility, and potential shifts to inform your next move.
26,831 articlesA new wave of weight-loss therapies aims to beat current GLP-1 drugs by reducing side effects and daily dosing. Inves...
OpenAI has filed confidential IPO paperwork with the SEC, signaling a public listing could be on the horizon. The mov...
Investors are turning to a Buffett-inspired approach to generate steady income. This article breaks down a five-stock...
A fresh BIT Research note argues that Bitcoin may complete its bear market during the June-July World Cup window, poi...
Bitcoin has fallen about 20% in the last 30 days, shaking investors and raising questions about what comes next. This...
SpaceX's IPO headlines would be enormous and tempting. This article shares the one clear message I’d tell every inves...
A leading market strategist warns that yen carry-trade unwinds and weakness in Korea's KOSPI could foreshadow broader...
As the U.S. ramps up nuclear capacity, one stock could benefit from policy shifts, domestic fuel security, and growin...
As Medicare IRMAA surcharges loom, retirees face higher taxes on RMDs and reduced spendable cash. This report explain...
A tiny investment can become a huge winner when the business model scales with a durable moat. This guide breaks down...
The S&P 500 is posting its fastest earnings growth in nearly five years, led by under-the-radar firms across multiple...
A six-month surge in Asia’s 50 largest stocks turned a $10,000 stake into $15,267 by early June 2026, outperforming t...